Digoxin as an emerging therapy in noncardiac diseases

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The cardiac glycoside (CG) digoxin is a generic drug approved for the treatment of heart failure and supraventricular arrhythmias. Over the past few decades, substantial strides have been made toward repurposing digoxin to treat various noncardiac diseases. Here, we evaluate recent insights into basic and clinical work related to noncardiac use of digoxin.

Cite

CITATION STYLE

APA

Dashti, F., Jamshed, F., Ouyang, X., Mehal, W. Z., & Banini, B. A. (2023, April 1). Digoxin as an emerging therapy in noncardiac diseases. Trends in Pharmacological Sciences. Elsevier Ltd. https://doi.org/10.1016/j.tips.2022.10.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free